Annika Raitala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Annika Raitala has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
J Karjalainen
1 shared publicationJ. Karjalainen
Department of Respiratory Medicine
1 shared publicationJussi Karjalainen
Department of Respiratory Medicine, Tampere University Hospital, Tampere, Finland
1 shared publicationM Hurme
1 shared publicationM. Hurme
Department of Microbiology and Immunology, Medical School, University of Tampere
1 shared publicationM. Pertovaara
Department of Internal Medicine, Section of Rheumatology
1 shared publication
Latest Publications
- 1 February 2007
- Published by Elsevier in Molecular Immunology
- Vol. 44 (5) , 1011-1014
Helicobacter pylori-induced indoleamine 2,3-dioxygenase activity in vivo is regulated by TGFB1 and CTLA4 polymorphisms
- 1 February 2007
- Published by Elsevier in Molecular Immunology
- Vol. 44 (5) , 1011-1014
Helicobacter pylori-induced indoleamine 2,3-dioxygenase activity in vivo is regulated by TGFB1 and CTLA4 polymorphisms
- 1 March 2006
- Published by Elsevier in Molecular Immunology
- Vol. 43 (7) , 1054-1056
Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy
- 1 March 2006
- Published by Elsevier in Molecular Immunology
- Vol. 43 (7) , 1054-1056
Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy
- 22 April 2005
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 61 (4) , 387-390
Association of Interferon‐gamma +874(T/A) Single Nucleotide Polymorphism with the Rate of Tryptophan Catabolism in Healthy Individuals
Mechanisms induced by tryptophan (trp) catabolism are important in the regulation of both normal and pathogenetic immune responses. The key enzyme is indoleamine‐pyrrole 2,3‐dioxygenase (EC 1.13.11.42) (IDO) which converts trp to kynurenine (kyn), the main toxic metabolite. It is known that interferon‐gamma (IFN‐γ) is able to activate IDO. We wanted to analyse whether the strength of this mechanism would be under genetic control. To this end, we analysed the IFN‐γ+874(T/A) genotypes, which are known to have an effect on IFN‐γ production, of 309 healthy blood donors and correlated these to the levels of trp and kyn in their blood. The data obtained demonstrate that the presence of the high producer T allele was associated with increased IDO activity (i.e. elevated kyn and kyn/trp levels), but this effect was observed only in females. These data show that trp catabolism is genetically controlled by the IFN‐γ gene and may thus be operative in those disease conditions associated with the polymorphisms of the IFN‐γ gene.
- 22 April 2005
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 61 (4) , 387-390
Association of Interferon‐gamma +874(T/A) Single Nucleotide Polymorphism with the Rate of Tryptophan Catabolism in Healthy Individuals
Mechanisms induced by tryptophan (trp) catabolism are important in the regulation of both normal and pathogenetic immune responses. The key enzyme is indoleamine‐pyrrole 2,3‐dioxygenase (EC 1.13.11.42) (IDO) which converts trp to kynurenine (kyn), the main toxic metabolite. It is known that interferon‐gamma (IFN‐γ) is able to activate IDO. We wanted to analyse whether the strength of this mechanism would be under genetic control. To this end, we analysed the IFN‐γ+874(T/A) genotypes, which are known to have an effect on IFN‐γ production, of 309 healthy blood donors and correlated these to the levels of trp and kyn in their blood. The data obtained demonstrate that the presence of the high producer T allele was associated with increased IDO activity (i.e. elevated kyn and kyn/trp levels), but this effect was observed only in females. These data show that trp catabolism is genetically controlled by the IFN‐γ gene and may thus be operative in those disease conditions associated with the polymorphisms of the IFN‐γ gene.